Axel Sjöblad, Managing Director of BioGaia AB, summarizes the third quarter of 2017 and answers questions regarding:
- Net sales in Q3 by 17% and operating profit strengthened compared with the same period previous year.
- Sales for Adult Health were strong and increased 58% Y/Y.
- The reason behind the strong improvement in Americas.
- The situation in Italy.
- A number of distribution agreements that are now beginning to come into effect.
- BioGaia is shareholder in MetaboGen.
Listen to telephone conference from 25 October 2017 about Interim report 1 January-30 September 2017